NCT07248449 Physical Fitness in DS: A Comparison of Cuevas Medak and Rebound Exercises
| NCT ID | NCT07248449 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Down Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 22 participants |
| Start Date | 2025-10-22 |
| Primary Completion | 2026-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22 participants in total. It began in 2025-10-22 with a primary completion date of 2026-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial investigates the comparative effects of Cuevas Medak Exercises Vs Rebound Exercises on physical fitness in DS. The.current study will be single blinded randomized clinical design in which nonprobability convenience sampling technique will be used. Inclusion criteria will be Down Syndrome. both genders will be included. The study involves 22 DS aged 3-8, will be assigned using lottery method, the participants will be randomly divided into two groups. One group will be given Cuevas Medek Exercises and the other with Rebound exercises. SAMU-Disability Fitness (DISFIT) battery will be used to assess the Physical Fitness in Down syndrome. Both groups will be given three treatment session per week for 12 weeks and total time for each session will be 30-45 minutes. . Data will be analyzed through SPSS version 26.0
Eligibility Criteria
Inclusion Criteria: * Children with Down syndrome * Age 3-8 years Both genders * Children who were able to understand the commands given to them. * They were able to stand and walk independently. Exclusion Criteria: * Patients with medical conditions that would severely limit their participation in the study * Hearing loss * Contracture * Musculoskeletal disorders, * Atlanto-axial instability * Cardiac anomalies * Thyroid abnormality * Seizures * Uncorrected vision problems * Orthopedic surgery or spasticity-reduction intervention
Contact & Investigator
Ayesha Afzal, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07248449 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 8 Years, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07248449 currently recruiting?
Yes, NCT07248449 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07248449 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07248449 clinical trial?
NCT07248449 is sponsored by Riphah International University. The principal investigator is Ayesha Afzal, MS-PT at Riphah International University. The trial plans to enroll 22 participants.